Erasca Ownership | Who Owns Erasca?

Overview ForecastFinancials Chart Transcripts

Erasca Ownership Summary

Erasca is owned by 74.89% institutional investors, 12.40% insiders, and 12.72% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 7.45% of ERAS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.51% of its assets in Erasca shares.

ERAS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Erasca	74.89%	12.40%	12.72%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Frazier life sciences management	16.22M	7.45%	$38.27M
Blackrock	10.61M	7.02%	$25.04M
T. rowe price investment management	16.71M	5.92%	$41.94M
Vr adviser	16.22M	5.74%	$40.70M
Blackrock funding, inc. /de	15.76M	5.58%	$39.56M
Vanguard group	12.67M	4.49%	$31.81M
Logos global management lp	12.50M	4.43%	$31.38M
Artal group	9.63M	4.42%	$22.73M
Suvretta capital management	12.32M	4.36%	$30.91M
Arch venture management	11.06M	3.92%	$27.75M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Arch venture management	11.06M	12.05%	$27.75M
Silverarc capital management	7.54M	4.14%	$18.94M
Logos global management lp	12.50M	3.67%	$31.38M
5am venture management	5.41M	3.24%	$13.57M
Vr adviser	16.22M	2.79%	$40.70M
Edbi pte	888.89K	2.36%	$2.23M
Octagon capital advisors lp	5.14M	2.12%	$12.89M
Vivo capital	6.76M	1.90%	$16.96M
Frazier life sciences management	16.22M	1.79%	$38.27M
Suvretta capital management	12.32M	1.05%	$30.91M

Top Buyers

Holder	Shares	% Assets	Change
Frazier life sciences management	16.22M	1.79%	16.22M
Octagon capital advisors lp	5.14M	2.12%	5.14M
Artal group	9.63M	0.58%	4.91M
Blackrock	10.61M	0.00%	3.63M
Millennium management	4.18M	0.01%	1.77M

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-6.17M
Balyasny asset management	-	-	-4.32M
Janus henderson group	73.20K	0.00%	-4.04M
Schroder investment management group	-	-	-1.93M
Cvi	-	-	-1.46M

New Positions

Holder	Shares	% Assets	Change	Value
Frazier life sciences management	16.22M	1.79%	16.22M	$38.27M
Octagon capital advisors lp	5.14M	2.12%	5.14M	$12.89M
Wellington management group llp	465.67K	0.00%	465.67K	$1.17M
Ipg investment advisors	169.98K	0.10%	169.98K	$426.64K
Highvista strategies	135.67K	0.13%	135.67K	$340.52K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-18.00
Us bancorp \de\	-84.00
Capital performance advisors llp	-332.00
Massmutual trust co fsb/adv	-333.00
Gps wealth strategies group	-350.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	145	8.21%	211,469,201	-8.86%	74	1.11%	78	-	38	31.03%
Sep 30, 2024	134	5.51%	232,039,374	13.99%	82	0.94%	78	-13.33%	29	26.09%
Jun 30, 2024	127	15.45%	203,567,433	180.08%	93	4.04%	90	87.50%	23	-47.73%
Mar 31, 2024	110	-7.56%	72,682,320	4.96%	48	2.26%	48	-30.43%	44	33.33%
Dec 31, 2023	119	8.18%	69,248,421	-2.85%	46	2.05%	69	21.05%	33	17.86%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	7.11M	2.51%	-
iShares Russell 2000 ETF	4.78M	1.69%	-41.41K
T. Rowe Price Small-Cap Value	4.44M	1.57%	-
T. Rowe Price Small-Cap Stock	3.58M	1.26%	137.99K
T. Rowe Price US Small-Cap Core Equity	3.45M	1.22%	-197.13K
Vanguard Institutional Extnd Mkt Idx Tr	3.42M	1.21%	7.26K
T. Rowe Price U.S. SC Value Eq Tr-Z	2.77M	0.98%	123.99K
T. Rowe Price U.S. SC Value Eq Tr-D	2.77M	0.98%	123.99K
SPDR® S&P Biotech ETF	2.23M	0.79%	-13.57K
T. Rowe Price Instl Small-Cap Stock	1.85M	0.65%	69.80K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 21, 2024	Casdin Alexander W.	-	Buy	$181.92K
Dec 06, 2023	Start Valerie Denise Harding	-	Buy	$18.48K
Dec 05, 2023	Lim Jonathan E	Chairman & CEO	Buy	$1.22M
Dec 06, 2023	Lim Jonathan E	Chairman & CEO	Buy	$478.42K
Dec 04, 2023	Casdin Alexander W.	-	Buy	$49.78K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q2	1	-
2024 Q1	-	-
2023 Q4	5	-
2023 Q2	2	-

ERAS Ownership FAQ

Who Owns Erasca?

Erasca shareholders are primarily institutional investors at 74.89%, followed by 12.40% insiders and 12.71% retail investors. The average institutional ownership in Erasca's industry, Biotech Stocks , is 68.48%, which Erasca exceeds.

Who owns the most shares of Erasca?

Erasca’s largest shareholders are Frazier life sciences management (16.22M shares, 7.45%), Blackrock (10.61M shares, 7.02%), and T. rowe price investment management (16.71M shares, 5.92%). Together, they hold 20.38% of Erasca’s total shares outstanding.

Does Blackrock own Erasca?

Yes, BlackRock owns 7.02% of Erasca, totaling 10.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 25.04M$. In the last quarter, BlackRock increased its holdings by 3.63M shares, a 52.00% change.

Who is Erasca’s biggest shareholder by percentage of total assets invested?

Arch venture management is Erasca’s biggest shareholder by percentage of total assets invested, with 12.05% of its assets in 11.06M Erasca shares, valued at 27.75M$.

Who is the top mutual fund holder of Erasca shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Erasca shares, with 2.51% of its total shares outstanding invested in 7.11M Erasca shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools